Fixational Microsaccades in Patients With Parkinson Disease
Daniela G Teijelo1, Andrew Hoover, Byron L Lam
1Department of Ophthalmology (DGT, AH, BLL, JW, HJ), Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida; Duke University School of Medicine (AH), Durham, North Carolina; C.Light Technologies (JX, EC, CKS), Inc, Cambridge, Massachusetts; Department of Neurology (IH, HJ), University of Miami Miller School of Medicine, Miami, Florida; and Department of Kinesiology and Sports Sciences (JS), University of Miami, Coral Gables, Florida.
Parkinson disease (PD) patients exhibit altered fixational microsaccades (FM), characterized by larger, more frequent, and quicker eye movements. These changes correlate with disease severity, suggesting FM as a potential biomarker for PD progression.
Area of Science:
- Ophthalmology
- Neuroscience
- Biomarkers
Background:
- Fixational microsaccades (FM) are small, involuntary eye movements essential for visual stability.
- Altered FM patterns are linked to central nervous system disorders, including multiple sclerosis.
- This study investigates FM characteristics in Parkinson disease (PD) patients.
Purpose of the Study:
- To characterize fixational microsaccades (FM) in individuals with Parkinson disease (PD).
- To explore the relationship between FM parameters and PD severity.
Main Methods:
- Retinal motion traces were recorded from 14 PD patients and 17 controls using a tracking scanning laser ophthalmoscope (TSLO).
- Key FM metrics measured included number, amplitude, velocity, peak velocity, and frequency.
- Correlation analysis was performed between FM measures and the MDS UPDRS III motor subscale and Hoehn and Yahr Stage.
Main Results:
- PD patients displayed significantly higher numbers, larger amplitudes, and increased velocities and frequencies of FM compared to controls (P < 0.05).
- Average FM amplitude, velocity, and peak velocity strongly correlated with PD severity as assessed by UPDRS III and Hoehn and Yahr Stage (r = 0.56–0.62, P < 0.05).
Conclusions:
- This is the first study to characterize FM in PD patients using TSLO.
- TSLO demonstrated high precision for detailed retinal imaging with minimal motion artifact.
- Impaired FM in PD correlates with disease severity, indicating potential as a biomarker for progression and treatment response.
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease ll: Pathophysiology
Parkinson's Disease: Overview
Parkinson Disease l: Introduction


